ConceptioArchiveClinicalTrials.gov
ClinicalTrials.govpublic full text

CAR-T for Autoimmune Hemolytic Anemia Patients Who Have Failed Three or More Lines of Therapy

Institute of Hematology & Blood Diseases Hospital, China · 2024
ClinicalTrials.gov · Datasets · License: Public Domain · 2024
Open Source ↗
autoimmune hemolytic anemia, cd19 car-t cell infusion, thiscart19a, relapsed/refractory after receiving three or more lines of therapy, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 827811
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.